Q32 Bio
Business Services · Minnesota, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
830 Winter St Fl 2, Waltham, Minnesota, ...Phone Number
(781) 999-0232Website
www.q32bio.comRevenue
$53.7 MillionStock Symbol
QTTBIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
2
1
1
1
1
1
About Q32 Bio
Q32 Bio is a clinical-stage biotechnology company focused on developing innovative therapies for autoimmune and inflammatory diseases. The company leverages advances in immunology to create treatments that aim to restore balanced immune function and address the underlying causes of chronic immune-mediated conditions. Its research centers on targeted biologic approaches designed to improve patient outcomes while minimizing unwanted immune effects. Q32 Bio is advancing a pipeline of therapeutic candidates through clinical development.Explore more
Q32 Bio Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Q32 Bio your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if Q32 Bio had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if Q32 Bio is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Q32 Bio
Product Launch: Get notified when Q32 Bio launches new products
Funding: Get notified immidiatlly once Q32 Bio has new funding data
Earning: See what the market has to say on Q32 Bio recently announced quarterly report
Check if Q32 Bio has recently received funding, and reach out quickly before it becomes old news!
Q32 Bio, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Recommended Actions
Find VP level buyers at Q32 Bio
Find more new buyers
Compare Similar Companies to Q32 Bio
Compare insights from companies similar to Q32 Bio, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Q32 Bio is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Q32 Bio is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Q32 Bio.
Q32 Bio financials insights
Gather financial insights about Q32 Bio, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2020
Series A
$46M
Series B
$60M
2026
Stock/Share Issuance
$55M
Q32 Bio Tech Stack
A closer look at the technologies used by Q32 Bio
Most Recent Scoops
Person-Based
Clinical Operations
Person-Based
Medical Research, Pharmaceuticals, Clinical Operations
Person-Based
Medical Research, Clinical Operations
Person-Based
Contracts, Finance, Financing & Debt
Person-Based
Medical Research, Pharmaceuticals
Q32 Bio News & Media
Q32 Bio Announces Upcoming Late-Breaking Presentation of Results from Part B of the SIGNAL-AA Clinical Trial of Bempikibart in Alopecia Areata at the European Academy of Dermatology and Venereology Congress 2026
-- Late-breaking oral and poster presentations to feature additional 36-week results and initial findings from the 16-week off-drug period from Part B of the SIGNAL-AA clinical trial of bempikibart in alopecia areata -- WALTHAM, Mass., Sept. 21, 2026 /PRNewswire/ -- Q32 Bio Inc. (Nasdaq:...Q32 Bio Inc. (QTTB) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
Q32 Bio Inc. (QTTB) Morgan Stanley 24th Annual Global Healthcare Conference September 15, 2026 11:30 AM EDTCompany ParticipantsShelia Violette - Co-founder,...Q32 Bio Appoints José Trevejo, M.D., Ph.D., as Chief Medical Officer and Ellie Hershberger, Pharm.D., as Chief Development Officer
-- Dr. Trevejo is a physician-scientist and biotechnology executive with over 20 years of experience spanning dermatology and late-stage clinical development -- -- Dr. Hershberger is a drug development leader with over 30 years of experience spanning late-stage development operations and...Q32 Bio to Participate in Upcoming September Investor Conferences
WALTHAM, Mass., Sept. 1, 2026 /PRNewswire/ -- Q32 Bio Inc. (Nasdaq: QTTB) ("Q32 Bio"), a clinical stage biotechnology company focused on developing innovative therapies for alopecia areata ("AA") and other autoimmune and inflammatory diseases, today announced that management will...
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Q32 Bio
Sign Up For FreeTo access detailed company insights
Q32 Bio is a clinical-stage biotechnology company focused on developing innovative therapies for autoimmune and inflammatory diseases. The company leverages advances in immunology to create treatments that aim to restore balanced immune function and address the underlying causes of chronic immune-mediated conditions. Its research centers on targete... Read More
